Pancreatic Cancer Research

ResearcherBrown UniversityActive in the last 2 years

Sherise Chantell Rogers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4886-3169; OpenAlex author ID A5051632076; NIH RePORTER profile ID 15599018. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
44
Papers, trials and grants by year

2023: 6 papers · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers, 1 grant

Papers 13

  1. Racial Disparities in Non-Stigmatized Supportive Care Medication Use in Pancreatic Cancer. Co-author DOI 10.1016/j.jpainsymman.2026.02.025↗
  2. Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial. Co-author DOI 10.1093/oncolo/oyag250↗
  3. Socioeconomic Disparities in Supportive Care Medication Use Among US Medicare Beneficiaries with Pancreatic Cancer. Co-author DOI 10.1177/10732748261491721↗
  4. ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer. Co-author DOI 10.3390/cancers17050870↗
  5. Cachexia in Pancreatic Cancer: New Insights to Impact Quality of Life and Survival. Co-author DOI 10.3390/nu17193064↗
  6. Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic canc… Co-author DOI 10.1016/j.ejps.2024.106754↗
  7. Analysis of pancreatic cancer treatment and survival disparities in Florida throughout the Covid-19 pandemic. Last author DOI 10.1016/j.jnma.2024.07.004↗
  8. National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer. Co-author DOI 10.1016/j.hpb.2023.06.018↗
  9. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. Last author DOI 10.1016/j.jnma.2023.01.008↗
  10. Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapie… Co-author DOI 10.1158/1055-9965.epi-23-0251↗
  11. A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma. First author DOI 10.2217/fon-2023-0256↗
  12. The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer. Co-author DOI 10.3390/cancers15245708↗
  13. Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer. Co-author DOI 10.3390/ijms24054288↗

Grants 1

  1. Community Outreach Core U54CA233444↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Edward Agyare · 5 shared papers, 2023–2025 · strength 1.10
  2. Bo Han · 5 shared papers, 2023–2025 · strength 1.10
  3. Diana J. Wilkie · 4 shared papers, 2023–2026 · strength 1.05
  4. John M. Allen · 4 shared papers, 2023–2026 · strength 0.95
  5. Ibrahim Nassour · 4 shared papers, 2023–2026 · strength 0.80
  6. Lisa J. Scarton · 3 shared papers, 2023–2026 · strength 0.76
  7. Thomas J. George · 4 shared papers, 2023–2026 · strength 0.74
  8. Ryan Michael Thomas · 3 shared papers, 2023–2026 · strength 0.69
  9. Esther Frimpong · 3 shared papers, 2023–2024 · strength 0.58
  10. Kathryn E. Hitchcock · 3 shared papers, 2023–2026 · strength 0.56
  11. Jesus C. Fabregas · 3 shared papers, 2023–2026 · strength 0.56
  12. Steven J. Hughes · 3 shared papers, 2023–2026 · strength 0.56
  13. Yingwei Yao · 1 shared grant, 2026 · strength 0.48
  14. Ernest Kaninjing · 1 shared grant, 2026 · strength 0.48
  15. Rodrigo Cristofoletti · 1 shared grant, 2026 · strength 0.48
  16. Kinfe Ken Redda · 1 shared grant, 2026 · strength 0.48
  17. Paul Okunieff · 1 shared grant, 2026 · strength 0.48
  18. Chanita A. Hughes-Halbert · 1 shared grant, 2026 · strength 0.48
  19. Saunjoo Yoon · 1 shared grant, 2026 · strength 0.48
  20. Mariana C Stern · 1 shared grant, 2026 · strength 0.48
  21. Sulma Ibrahim Mohammed · 1 shared grant, 2026 · strength 0.48
  22. Tianze Jiao · 1 shared grant, 2026 · strength 0.48
  23. Naziheh Assarzadegan · 1 shared grant, 2026 · strength 0.48
  24. FERN Jureidini WEBB · 1 shared grant, 2026 · strength 0.48
  25. Romonia Renee REAMS · 1 shared grant, 2026 · strength 0.48

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.